微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 7.21% | -20.33% | 37.6% | 47/160 | 4.14% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 5.24% | -10.73% | 72.37% | 35/160 | 2.6% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 3.04% | -15.32% | -71.35% | 32/160 | 2.3% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 10.61% | 8.49% | 17.24% | 27/160 | -0.96% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 9.05% | 16.47% | 54.17% | 29/160 | 2.37% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 5.87% | 26.24% | 63.51% | 30/160 | 1.51% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 3.59% | 16.94% | -63.29% | 24/160 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 9.78% | 12.8% | 25.87% | 45/160 | 0.8% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 7.77% | -9.02% | 67.1% | 48/160 | 2.89% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 4.65% | -16.67% | 51.47% | 52/160 | 2.24% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 3.07% | 0.99% | -64.59% | 36/160 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 8.67% | -7.77% | 1.52% | 51/160 | 0.94% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 8.54% | 5.96% | 53.05% | 48/160 | 4.53% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 5.58% | 9.63% | 83.55% | 49/160 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 3.04% | 5.56% | -67.66% | 43/160 | 2.52% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 9.4% | 3.07% | 16.63% | 59/160 | 3.74% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 8.06% | -6.06% | 58.35% | 48/160 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 5.09% | 4.09% | 76.74% | 56/160 | 4.24% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 2.88% | 3.97% | -68.42% | 36/160 | 2.24% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 9.12% | 0.55% | 6.29% | 63/160 | 2.78% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 8.58% | 13.34% | 75.46% | 43/160 | 7.61% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 4.89% | 2.52% | 76.53% | 51/160 | 5.05% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 2.77% | 2.21% | -69.46% | 38/160 | 2.46% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 9.07% | 16.43% | 19.82% | 56/160 | 7.09% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 7.57% | -8.57% | 58.7% | 41/160 | 7.26% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 4.77% | 12.5% | 76.01% | 45/160 | 4.65% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 2.71% | 5.86% | -65.21% | 37/160 | 2.55% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 7.79% | 49.81% | -5.92% | 69/160 | 9.66% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 8.28% | 78.83% | 95.28% | 42/160 | 8.31% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 4.24% | 81.2% | 65.63% | 58/160 | 5.59% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 2.56% | 139.25% | -50.77% | 35/160 | 2.1% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 5.2% | 137.44% | 12.31% | 83/160 | 6.33% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 4.63% | 38.62% | 97.86% | 53/160 | 5.61% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | 2.34% | 178.57% | 118.69% | 65/160 | 3.53% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 1.07% | 37.18% | -51.14% | 56/160 | 2.65% | 贝达药业 | 16.78% | 行业排名> |
| 2015-12-31 | 2.19% | 338% | -34.43% | 84/160 | 11.35% | 河化股份 | 19.29% | 行业排名> |
| 2015-09-30 | 3.34% | 23.7% | 297.62% | 54/160 | 7.22% | 一品红 | 58.17% | 行业排名> |
| 2015-06-30 | 0.84% | 13.51% | 7.69% | 67/160 | 4.9% | 华东医药 | 36.97% | 行业排名> |
| 2015-03-31 | 0.78% | 333.33% | 56% | 54/160 | 2.41% | 华东医药 | 26.63% | 行业排名> |